BeOne Medicines (ONC) FCF Margin Growth (1y) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (ONC) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 811.00 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 19,111.00 |
| 10 | Incyte | 25.57 Bn | 21.04 Bn | 1.57 Bn | 2,747.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 869.00 |
| Mar 31, 2026 | 1,187.00 |
| Dec 31, 2025 | 2,689.00 |
| Sep 30, 2025 | 1,964.00 |
| Jun 30, 2025 | 3,910.00 |
| Mar 31, 2025 | 6,046.00 |
| Dec 31, 2024 | 5,814.00 |
| Sep 30, 2024 | 3,567.00 |
| Jun 30, 2024 | 4,766.00 |
| Mar 31, 2024 | 9,206.00 |
| Dec 31, 2023 | 5,596.00 |
| Sep 30, 2023 | 14,278.00 |
| Jun 30, 2023 | 5,103.00 |
| Mar 31, 2023 | -5,633.00 |
| Dec 31, 2022 | 17,542.00 |
| Sep 30, 2022 | 9,961.00 |
| Jun 30, 2022 | 18,507.00 |
| Mar 31, 2022 | -11,126.00 |
| Dec 31, 2021 | 7,559.00 |
| Sep 30, 2021 | 13,904.00 |